<unk> , a protease inhibitor sold under the brand name Norvir, is an antiretroviral medication used along with other medications to treat HIV/AIDS. This combination treatment is known as highly active antiretroviral therapy (HAART). Often a low dose is used with other protease inhibitors. It may also be used in combination with other medications for hepatitis C. It is taken by mouth. The tablets of<unk>  are not bioequivalent to capsules as tablets may result in higher peak plasma concentrations. Common side effects include nausea, vomiting, loss of appetite, diarrhea, and numbness of the hands and feet. Serious side effects include liver problems, pancreatitis, allergic reactions, and arrythmias. Serious interactions may occur with a number of other medications including amiodarone and simvastatin. At low doses it is considered to be acceptable for use during pregnancy.<unk>  is of the protease inhibitor class. Typically, however, it is used to inhibit the enzyme that metabolizes other protease inhibitors. This inhibition allows lower doses of these latter medications to be used.<unk>  was patented in 1989 and came into medical use in 1996. It is on the World Health Organization's List of Essential Medicines.<unk>  capsules were approved as a generic medication in the United States in 2020.
Ritonavir
Amprenavir
Saquinavir
Fosamprenavir
Indinavir
Nelfinavir
Atazanavir
Entecavir